The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability ...

Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Novo Nordisk's launch of NovoCare is showing signs of boosting Wegovy's sales, and the E.U.-U.S. trade deal adds stability ...

The deal was Novo Nordisk’s bid to grab back market share from the cheaper, knockoff versions that Hims & Hers and other ...

GLP-1 medications work by suppressing appetite and altering cravings. That means fewer impulse purchases, smaller baskets and ...

The GLP-1 medication program by MedVi is now available nationwide starting at $179. NEWARK, DE - MedVi Wellness, a leading tele ...

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest Pharmacy Market Outlet report, released in July. The report found that price pressures are easing in certain ...

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.